D. Structure of the Consortium (Tag: March 2010)

April 2008 March 2010 May 2012, Current

The ICGC is a confederation of members that share the common goals and principles described in this document and have agreed to work in a coordinated and collaborative manner within a defined structure.

Members consist of Funding Members and Research Members, each of which is an individual or allied group that will provide a level of funding or scientific expertise sufficient to undertake a Cancer Genome Project involving characterization of a minimum of 500 unique cases for each cancer type or subtype. More than 500 samples may be required for tumors that demonstrate considerable heterogeneity. There are circumstances when 500 samples of a tumor type or subtype may be impractical (such as a rare cancer) or unnecessary (such as a tumor subtype that is known to be relatively homogeneous, based on pre-existing molecular studies). ICGC Research Members proposing to tackle such projects should provide the rationale for the choice of sample size. Each Member will have responsibility for financially or scientifically supporting a minimum of one Cancer Genome Project. Members wishing to support Cancer Genome Projects with fewer than 500 samples per tumor type should do so by clustering projects together. Research Members will need to have existing or committed funds from an ICGC Funding Member.

It is recognized that, at the outset, potential Funding Members may not yet have designated funds available to support a Cancer Genome Project and thus may be unable to immediately commit the requisite funds. Funding agencies with a prior record of funding large-scale cancer and/or genome projects will be provided an opportunity to join the ICGC in the absence of a qualifying research project for the first year to allow sufficient time for them to follow their normal policies and procedures to secure funds, to plan initiatives of this magnitude, and to make a firm funding commitment.

Categories of membership are defined as follows.